tiprankstipranks
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market
Holding WGS?
Track your performance easily

GeneDx Holdings (WGS) Financial Statements

569 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently ―. The company's EPS TTM is $-3.171; its P/E ratio is ―; GeneDx Holdings is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 76.87M$ 70.51M$ 62.42M$ 53.30M$ 48.71M
Gross Profit$ 47.83M$ 42.95M$ 37.41M$ 25.26M$ 18.76M
EBIT$ -8.36M$ -29.36M$ -19.72M$ -42.46M$ -46.29M
EBITDA$ -8.36M$ -29.36M$ -14.48M$ -42.46M$ -46.16M
Net Income Common Stockholders$ -8.31M$ -29.17M$ -20.24M$ -42.29M$ -50.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 116.46M$ 106.86M$ 112.91M$ 114.30M$ 156.66M
Total Assets$ 408.84M$ 389.10M$ 394.53M$ 417.29M$ 476.39M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 204.34M$ 182.75M$ 187.31M$ 163.03M$ 180.28M
Stockholders Equity$ 204.50M$ 194.04M$ 207.22M$ 254.26M$ 296.11M
Cash Flow-
Free Cash Flow$ -5.04M$ -5.86M$ -16.86M$ -41.09M$ -52.17M
Operating Cash Flow$ -4.39M$ -4.50M$ -16.41M$ -41.23M$ -53.50M
Investing Cash Flow$ -7.75M$ -22.70M$ 843.00K$ -27.13M$ -11.27M
Financing Cash Flow$ 13.97M$ -391.00K$ -438.00K$ -911.00K$ 7.39M
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis